The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.
making it more affordable and achievable than discovering a brand-new drug, with patients gaining access to new therapies more quickly. This is particularly important for certain neglected ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including Ozempic, drugs for HIV, cancer and many others.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results